Vivos Therapeutics Stock Price

0.00 (0.0%)
Volume 0
Bid Price 2.35
Ask Price 2.54
News -
Day High


52 Week Range


Day Low
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Vivos Therapeutics Inc VVOS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 2.50 04:42:13
Open Price Low Price High Price Close Price Prev Close
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 2.50 USD


Draw Mode:

Vivos Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 57.53M 23.01M 18.07M $ 13.07M $ -12.06M -1.40 -1.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 3.10%

more financials information »

Vivos Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VVOS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.193.502.002.494,329,9330.3114.16%
1 Month2.343.501.62752.336,730,9640.166.84%
3 Months3.984.141.62752.352,333,198-1.48-37.19%
6 Months3.657.091.62754.372,681,576-1.15-31.51%
1 Year6.7210.85951.62754.531,465,349-4.22-62.8%
3 Years7.0714.411.62754.811,395,477-4.57-64.64%
5 Years7.0714.411.62754.811,395,477-4.57-64.64%

Vivos Therapeutics Description

Vivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for adult patients suffering from sleep-disordered breathing, including obstructive sleep apnea (OSA). The Vivos treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for people with mild-to-moderate OSA. Vivos oral appliances have been used to treat over 15,000 patients worldwide by more than 1,100 trained dentists.

Your Recent History
Vivos Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.